This paper reports the investigation on synthesis and magnetic characterization of Ni substituted Co0.8Zn0.2Fe2O4 nano-particles. The nano-particles of Co(0.8-x)Ni(x)Zn(0.2)Fe2)O4 (x = 0.15, 0.20, 0.35, 0.50, 0.65) were prepared by co-precipitation method. The X-ray diffraction analysis confirmed the formation of single-phase face centered cubic (fcc) spinal structure. The lattice parameter decreased as Ni concentration increased from x = 0 (a = 8.388 A) to x = 0.65 (a = 8.3612 A). The morphology of the particles examined through high-resolution TEM showed a well-isolated and less agglomerated homogeneous distribution of nano-particles which suggests that co-precipitation method is beneficial for magnetic nano-materials synthesis and their characterization. The influence of Ni on magnetic behavior (saturation magnetization and 4piMs) of Co(0.8-x)Ni(x)Zn(0.2)Fe2O4 nano-materials have been evaluated and discussed.
[Show abstract][Hide abstract] ABSTRACT: In the present work, the sinterability and formation of nanosized yttrium iron garnet (Y 3 Fe 5 O 12), yttrium perovskite ferrite (YFeO 3), cobalt, nickel and zinc iron spinel (CoFe 2 O 4 , NiFe 2 O 4 and ZnFe 2 O 4 , respectively) powders by an aqueous sol-gel processes are investigated. The metal ions, generated by dissolving starting materials of transition metals in the diluted acetic acid were complexed by 1,2-ethanediol to obtain the precursors for the transition metal ferrite ceramics. The phase purity of synthesized nano-compounds was characterized by infrared spectroscopy (IR) and powder X-ray diffraction analysis (XRD). The microstructural evolution and morphological features of obtained transition metal ferrites were studied by scanning electron microscopy (SEM).
[Show abstract][Hide abstract] ABSTRACT: The objective of this study was to evaluate the synthesis and biocompatibility of Fe(3)O(4) nanoparticles and investigate their therapeutic effects when combined with magnetic fluid hyperthermia on cultured MCF-7 cancer cells.
Magnetic Fe(3)O(4) nanoparticles were prepared using a coprecipitation method. The appearance, structure, phase composition, functional groups, surface charge, magnetic susceptibility, and release in vitro were characterized by transmission electron microscopy, x-ray diffraction, scanning electron microscopy-energy dispersive x-ray spectroscopy, and a vibrating sample magnetometer. Blood toxicity, in vitro toxicity, and genotoxicity were investigated. Therapeutic effects were evaluated by MTT [3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide] and flow cytometry assays.
Transmission electron microscopy revealed that the shapes of the Fe(3)O(4) nanoparticles were approximately spherical, with diameters of about 26.1 ± 5.2 nm. Only the spinel phase was indicated in a comparison of the x-ray diffraction data with Joint Corporation of Powder Diffraction Standards (JCPDS) X-ray powder diffraction files. The O-to-Fe ratio of the Fe(3)O(4) was determined by scanning electron microscopy-energy dispersive x-ray spectroscopy elemental analysis, and approximated pure Fe(3)O(4). The vibrating sample magnetometer hysteresis loop suggested that the Fe(3)O(4) nanoparticles were superparamagnetic at room temperature. MTT experiments showed that the toxicity of the material in mouse fibroblast (L-929) cell lines was between Grade 0 to Grade 1, and that the material lacked hemolysis activity. The acute toxicity (LD(50)) was 8.39 g/kg. Micronucleus testing showed no genotoxic effects. Pathomorphology and blood biochemistry testing demonstrated that the Fe(3)O(4) nanoparticles had no effect on the main organs and blood biochemistry in a rabbit model. MTT and flow cytometry assays revealed that Fe(3)O(4) nano magnetofluid thermotherapy inhibited MCF-7 cell proliferation, and its inhibitory effect was dose-dependent according to the Fe(3)O(4) nano magnetofluid concentration.
The Fe(3)O(4) nanoparticles prepared in this study have good biocompatibility and are suitable for further application in tumor hyperthermia.
International Journal of Nanomedicine 09/2012; 7:4973-82. DOI:10.2147/IJN.S35140 · 4.38 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.